Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now
Close

Novo Nordisk A/S Class B (NOVOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
761.4 -3.3    -0.43%
30/09 - Closed. Currency in DKK ( Disclaimer )
  • Volume: 1,914,191
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 758.2 - 769.1
Type:  Equity
Market:  Denmark
ISIN:  DK0060534915 
S/N:  1742564000
Novo Nordisk B 761.4 -3.3 -0.43%

NOVOb Financial Summary

 
See below for an overview of the Novo Nordisk A/S Class B financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Novo Nordisk A/S reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was DKK 41,265 million compared to DKK 33,041 million a year ago. Net income was DKK 13,318 million compared to DKK 12,123 million a year ago. Basic earnings per share from continuing operations was DKK 5.87 compared to DKK 5.26 a year ago. Diluted earnings per share from continuing operations was DKK 5.86 compared to DKK 5.26 a year ago.For the six months, sales was DKK 83,296 million compared to DKK 66,845 million a year ago. Net income was DKK 27,528 million compared to DKK 24,746 million a year ago. Basic earnings per share from continuing operations was DKK 12.11 compared to DKK 10.73 a year ago. Diluted earnings per share from continuing operations was DKK 12.08 compared to DKK 10.71 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

NOVOb Income Statement

Gross margin TTM 83.92%
Operating margin TTM 42.68%
Net Profit margin TTM 32.14%
Return on Investment TTM 59.92%
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 42031 38333 35622 33041
Gross Profit 35114 32092 29563 27494
Operating Income 19147 13634 15249 14779
Net Income 14210 10892 12119 12123

NOVOb Balance Sheet

Quick Ratio MRQ 0.66
Current Ratio MRQ 0.94
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 34.16%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 197136 194508 174084 158095
Total Liabilities 130586 123762 107972 92536
Total Equity 66550 70746 66112 65559

NOVOb Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  24.67%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 3 Months 0 Months 9 Months 6 Months
Cash From Operating Activities 23586 55000 58017 36510
Cash From Investing Activities -1907 -31605 -11002 -6367
Cash From Financing Activities -19135 -25493 -30042 -18311
Net Change in Cash 2489 -1507 17264 12001
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email